Clinical trials recruiting for ANCA Associated Vasculitis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BCMA-CD19 CAR-T therapy | 1 |
| CAR T cell | 1 |
| CD19 or CD19-BCMA CAR-T | 1 |
| FKC289 | 1 |
| PRG-1801 (CAR-T against BCMA) | 1 |
Self-screener
Recruiting trials
- Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
- Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
- Multicenter Cohort Study of AAV in Hunan of China
- Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
- Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
- The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
Related conditions
Trials recruiting for ANCA Associated Vasculitis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for ANCA Associated Vasculitis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.